Two canine Merkel cell tumours: immunoexpression of c-KIT, E-cadherin, beta-catenin and S100 protein.

Canine Merkel cell tumours are rare neuroendocrine neoplasms that show a relatively benign biological behaviour when compared with their human counterparts. To date, little information is available on their immunohistochemical properties. This report describes the histopathological and immunohistochemical features of two such tumours. The tumours' immunoreactivity profile was studied with respect to different cellular molecules including chromogranin A (CGA), neurone-specific enolase (NSE), S100 protein, c-KIT, the cytokeratins (CKs) detected by pancytokeratin (AE1/AE3) antibodies (i.e. high molecular weight CKs 1, 2, 3, 4, 5, 6, 10, 14, 15 and 16, and low molecular weight CKs 7, 8 and 19) and three markers proposed to correlate with increased malignancy in human tumours: E-cadherin, beta-catenin and p63 protein. In both lesions, tumour cells were positive for cytokeratins, CGA, NSE, S100 and c-KIT. No immunostaining was observed for p63 protein, and there was no loss or change in E-cadherin or beta-catenin immunoexpression. These results suggest that the generally benign behaviour of canine Merkel cell tumours, when compared with their human counterparts, may be partly explained by the conservation of important intercellular adhesion molecules such as E-cadherin and beta-catenin. Additionally, expression of S100 but not of the p63 protein suggests that these canine tumours present a trend towards neural, rather than basal, epithelial differentiation and do not readily compare with human Merkel cell tumours.

[1]  F. Schmitt,et al.  Expression of E-cadherin, P-cadherin and β-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival , 2008 .

[2]  F. Gärtner,et al.  Expression of p63 normal canine skin and primary cutaneous glandular carcinomas. , 2008, Veterinary journal.

[3]  F. Schmitt,et al.  Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. , 2008, Veterinary journal.

[4]  R. M. Gil da Costa,et al.  CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers , 2007, BMC veterinary research.

[5]  V. Eusebi,et al.  p63 expression as a new prognostic marker in Merkel cell carcinoma , 2007, Cancer.

[6]  B. Swick,et al.  Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C‐KIT proto‐oncogene – implications for treatment with imatinib mesylate , 2007, Journal of cutaneous pathology.

[7]  F. Guarda,et al.  Use of s-100 and chromogranin a antibodies as immunohistochemical markers on detection of malignancy in aortic body tumors in dog. , 2006, The Journal of veterinary medical science.

[8]  P. Ihrke,et al.  Neural and Perineural Tumors , 2005 .

[9]  Z. Qian,et al.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas , 2004, Endocrine pathology.

[10]  T. Yoshino,et al.  Immunohistochemical Evaluation of a Malignant Intestinal Carcinoid in a Dog , 2003, Veterinary pathology.

[11]  S. Goerdt,et al.  Differentiation between Merkel Cell Carcinoma and Malignant Melanoma: An Immunohistochemical Study , 2000, Dermatology.

[12]  T. Nuttall,et al.  Skin Diseases of the Dog and Cat , 2018 .

[13]  M. Nagata,et al.  Immunohistochemical Diagnosis of a Merkel Cell Tumor in a Dog , 1998, Veterinary pathology.

[14]  A. Hauschild,et al.  [Cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V]. , 1998, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[15]  S. Hsu,et al.  A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. , 1981, American journal of clinical pathology.